CSF2 and lung adenocarcinoma: A high density of PD-L1-positive TAMs correlated with a worse clinical course in lung adenocarcinoma cases without EGFR mutation, and anti-GM-CSF antibody abrogated the PD-L1 overexpression in macrophages stimulated with cancer cell supernatant [70].